Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ISRCTN15681288) titled 'Restoring intestinal symbiosis for efficacy in IBS' on April 23.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: EnteroBiotix Limited
Condition:
Irritable Bowel Syndrome - constipation predominant (IBS-C)
Digestive System
Intervention:
Trial arms:
Participants will be randomly assigned in a 1:1:1 ratio to three treatment arms:
1) active treatment arm 1 - participants will receive study drug EBX-102-02
2) active treatment arm 2 - participants will receive study drug EBX-10...